[EN] SUBSTITUTED 2,3,5-TRIFLUORPHENYL OXAZOLIDINONES FOR USE AS ANTIBACTERIAL AGENTS [FR] 2,3,5-TRIFLUORPHENYL OXAZOLIDINONES SUBSTITUES A UTILISER EN TANT QU'AGENTS ANTIBACTERIENS
[EN] SUBSTITUTED 2,3,5-TRIFLUORPHENYL OXAZOLIDINONES FOR USE AS ANTIBACTERIAL AGENTS [FR] 2,3,5-TRIFLUORPHENYL OXAZOLIDINONES SUBSTITUES A UTILISER EN TANT QU'AGENTS ANTIBACTERIENS
[EN] SUBSTITUTED 2,3,5-TRIFLUORPHENYL OXAZOLIDINONES FOR USE AS ANTIBACTERIAL AGENTS<br/>[FR] 2,3,5-TRIFLUORPHENYL OXAZOLIDINONES SUBSTITUES A UTILISER EN TANT QU'AGENTS ANTIBACTERIENS
申请人:PHARMACIA & UPJOHN CO LLC
公开号:WO2005113520A1
公开(公告)日:2005-12-01
The present invention relates to trifluorphenyl oxazolidinones of formula (I) and to the process for the synthesis of the same. The compounds of the present invention are useful antimicrobial agents, effective against a number of human and veterinary pathogens.
[EN] SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER<br/>[FR] PYRAZINE-2-CARBOXAMIDES SUBSTITUÉES UTILISÉES EN TANT QU'INHIBITEURS DE HPK1 POUR LE TRAITEMENT DU CANCER
申请人:[en]ASTRAZENECA AB
公开号:WO2023001794A1
公开(公告)日:2023-01-26
There are disclosed certain substituted pyrazine-2-carboxamides of Formula (I), and pharmaceutically acceptable salts thereof, together with compositions containing them and their use in therapy. The compounds are inhibitors of hematopoietic progenitor kinase 1 (HPK1) and are thereby particularly useful in the treatment or prophylaxis of cancer.